Population pharmacokinetics and exposure‐response relationship for temsavir following fostemsavir administration in treatment‐experienced HIV patients

Population pharmacokinetics and exposure‐response relationship for temsavir following fostemsavir administration in treatment‐experienced HIV patients

Abstract Fostemsavir (FTR, GSK3684934; formerly BMS‐663068) is a human immunodeficiency virus type 1 (HIV‐1) attachment inhibitor approved for the treatment of multidrug‐resistant HIV‐1 infection in heavily treatment‐experienced (HTE) patients failing their current antiretroviral regimen. FTR is an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ridhi Parasrampuria, Nilay Thakkar, Katy Moore, Peter Ackerman, Mindy Magee
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Pharmacology Research & Perspectives
Subjects:
exposure response
fostemsavir
HIV‐1
population PK
Online Access:https://doi.org/10.1002/prp2.70023
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/prp2.70023

Similar Items